Skip to main content
logo
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
58.11
+0.95 (1.66%)
At close: Sep 22, 2026, 4:00 PM EDT
58.50
+0.39 (0.67%)
After-hours: Sep 22, 2026, 7:59 PM EDT

TG Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
441.49447.1823.3812.67-223.81-348.1
Depreciation & Amortization
0.120.060.070.210.30.28
Other Amortization
1.321.42.212.592.061.29
Loss (Gain) From Sale of Investments
-4.54-3.49-6.23-2.24-0.330.52
Stock-Based Compensation
81.1664.6742.5437.9344.6661.27
Other Operating Activities
-325.74-340.056.812.082.61.32
Change in Accounts Receivable
-170.05-176.44-78.09-51.091.39-1.39
Change in Inventory
-70.84-33.45-66.85-36.94--
Change in Accounts Payable
81.8255.8822.840.19-11.0115.99
Change in Unearned Revenue
5.776.3917.485.71-0.15-0.15
Change in Other Net Operating Assets
-12.07-46.91-4.68-2.538.13-26.67
Operating Cash Flow
17.88-24.77-40.52-31.41-176.17-295.63
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.49-0.21-0.05--0.01-0.4
Investment in Securities
22.3814.01-0.99-50.65-200.07
Investing Cash Flow
21.8913.8-1.04-50.65-20.01-0.33

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--244.8225-70
Long-Term Debt Repaid
---107.55--0.98-30
Net Debt Issued (Repaid)
492.66-137.2625-0.9840
Issuance of Common Stock
1.911.510.9147.830.582.44
Repurchase of Common Stock
-178.23-91.24-8.76---
Other Financing Activities
-2.6--0.89-0.13--1.02
Financing Cash Flow
313.73-89.73128.5372.71-0.3941.42

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
353.5-100.786.97-9.36-196.57-254.55

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
17.39-24.99-40.56-31.41-176.18-296.04
Free Cash Flow Growth
------
Free Cash Flow Margin
2.17%-4.05%-12.33%-13.44%-6326.18%-4425.70%
Free Cash Flow Per Share
0.11-0.15-0.25-0.21-1.30-2.24
Levered Free Cash Flow
59.13-43.98-62.02-47.55-97.44-166.6
Unlevered Free Cash Flow
81.43-28.49-49-42.05-92.91-164.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
32.6724.2518.478.775.453.47
Cash Income Tax Paid
14.127.880.5---
Change in Working Capital
-175.95-194.54-109.3-84.66-1.65-12.22
SEC Filings: 10-K · 10-Q